NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

You do understand the DCVax-L is not an established medicine?

This change you quoted refers to MAAs submitted for generics and biosimilars, Previously those had a very long time to get approved which looked odd. Sounds like the problem was that they were not validated (unlike novel drugs which have been). That caused many incomplete application to start the clock and screw up the MHRA stats.,

Means nothing for the DCVax-L submission. That either has or has not been validated, but the process started last year.